These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 36937854)

  • 21. Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study.
    Zhang MC; Fang Y; Xu PP; Dong L; Shen R; Huang YH; Fu D; Yan ZX; Cheng S; Jiang XF; Song Q; He Y; Zhao Y; Lu M; Ye J; Liu F; Cheng L; Wang CF; Wang L; Zhao WL
    Clin Transl Med; 2021 Dec; 11(12):e584. PubMed ID: 34923760
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary colon natural killer (NK)/T-cell lymphoma, nasal type, with perforations: a case report and literature review.
    Xie Y; Liu Y; Wen C; Li W; Lu X; Deng L
    Ann Palliat Med; 2021 Nov; 10(11):12025-12033. PubMed ID: 34872326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine activates type I interferon signaling to inhibit p53-deficient myeloid malignant cells.
    Wu J; Li Y; Wu J; Song H; Tang Y; Yan N; Wu L; Zhang S; Chang C; Lu M
    Clin Transl Med; 2021 Nov; 11(11):e593. PubMed ID: 34841700
    [No Abstract]   [Full Text] [Related]  

  • 24. Methylation alterations and advance of treatment in lymphoma.
    Liu MK; Sun XJ; Gao XD; Qian Y; Wang L; Zhao WL
    Front Biosci (Landmark Ed); 2021 Sep; 26(9):602-613. PubMed ID: 34590470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report.
    Xia L; Zhang HS; Bao J; Zhao YC; Xia HL
    Front Oncol; 2021; 11():706865. PubMed ID: 34277451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
    Chen M; Jiang Y; Cai X; Lu X; Chao H
    Int Immunopharmacol; 2021 Sep; 98():107829. PubMed ID: 34119916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.
    Patel AA; Cahill K; Saygin C; Odenike O
    Blood Adv; 2021 Apr; 5(8):2264-2271. PubMed ID: 33904891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses.
    Münz C
    Front Cell Infect Microbiol; 2021; 11():605258. PubMed ID: 33842383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study.
    Mi M; Zhang C; Liu Z; Wang Y; Li J; Zhang L
    Medicine (Baltimore); 2020 Dec; 99(49):e23412. PubMed ID: 33285732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis.
    Rosemarie Q; Sugden B
    Microorganisms; 2020 Nov; 8(11):. PubMed ID: 33228078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial.
    Gao L; Zhang Y; Wang S; Kong P; Su Y; Hu J; Jiang M; Bai H; Lang T; Wang J; Liu L; Yang T; Huang X; Liu F; Lou S; Liu Y; Zhang C; Liu H; Gao L; Liu J; Zhu L; Wen Q; Chen T; Wang P; Rao J; Mao M; Wang C; Duan X; Luo L; Peng X; Cassady K; Zhong JF; Zhang X
    J Clin Oncol; 2020 Dec; 38(36):4249-4259. PubMed ID: 33108244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
    Dalton T; Doubrovina E; Pankov D; Reynolds R; Scholze H; Selvakumar A; Vizconde T; Savalia B; Dyomin V; Weigel C; Oakes CC; Alonso A; Elemento O; Pan H; Phillip JM; O'Reilly RJ; Gewurz BE; Cesarman E; Giulino-Roth L
    Blood; 2020 May; 135(21):1870-1881. PubMed ID: 32157281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.
    Witte HM; Merz H; Biersack H; Bernard V; Riecke A; Gebauer J; Lehnert H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2020 Apr; 189(2):257-268. PubMed ID: 31958882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.
    Münz C
    Nat Rev Microbiol; 2019 Nov; 17(11):691-700. PubMed ID: 31477887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NADPH oxidase regulates paraquat and maneb-induced dopaminergic neurodegeneration through ferroptosis.
    Hou L; Huang R; Sun F; Zhang L; Wang Q
    Toxicology; 2019 Apr; 417():64-73. PubMed ID: 30797899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of AITL complicated by EBV-positive B cell and monoclonal plasma cell proliferation and effectively treated with lenalidomide.
    Kishimoto W; Takiuchi Y; Nakae Y; Tabata S; Fukunaga A; Matsuzaki N; Yuba Y; Kitano T; Arima N
    Int J Hematol; 2019 Apr; 109(4):499-504. PubMed ID: 30604313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway.
    Kong Z; Liu R; Cheng Y
    Biomed Pharmacother; 2019 Jan; 109():2043-2053. PubMed ID: 30551460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 5-Aza-2'-deoxycytidine (decitabine) on gene expression.
    Seelan RS; Mukhopadhyay P; Pisano MM; Greene RM
    Drug Metab Rev; 2018 May; 50(2):193-207. PubMed ID: 29455551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
    Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
    EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.